Physician profile
Ester B Pollard
NPI 1225002843
$28,348.11
in general payments reported to CMS, 2019-2025
78 companies · $3,430 in 2025
The $3,430 reported for 2025 was more than what 76% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,227 · 2020: $1,726 · 2021: $3,105 · 2022: $4,221 · 2023: $4,049 · 2024: $4,591 · 2025: $3,430.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Education: $508.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,560.89 |
| Education | $508.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rigel Pharmaceuticals, INC. | $6,216.75 | 2019-2025 | Rezlidhia, Tavalisse, Gavreto |
| Novartis Pharmaceuticals Corporation | $1,937.22 | 2019-2025 | Kisqali |
| E.R. Squibb & Sons, L.L.C. | $1,686.06 | 2019-2025 | Opdivo, Opdualag |
| Merck Sharp & Dohme LLC | $1,178.18 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Amgen INC. | $1,089.76 | 2019-2023 | Kyprolis, Nplate, Xgeva |
| Astrazeneca Pharmaceuticals Lp | $1,005.80 | 2019-2025 | Calquence, Imfinzi, Tagrisso |
| Pfizer INC. | $926.93 | 2019-2025 | |
| Genzyme Corporation | $800.40 | 2019-2025 | |
| Aveo Pharmaceuticals, INC. | $707.86 | 2021-2025 | Fotivda |
| Genentech USA, INC. | $673.93 | 2019-2025 | Tecentriq, Venclexta, Tecentriq Hybreza |
| Incyte Corporation | $644.35 | 2019-2025 | Jakafi |
| Astellas Pharma US INC | $587.51 | 2019-2025 | Xtandi, Padcev, Xospata |
| Glaxosmithkline, LLC. | $580.41 | 2019-2025 | Ojjaara, Shingrix |
| Pharmaessentia USA Corporation | $580.24 | 2022-2025 | Besremi |
| Sobi, INC | $514.76 | 2022-2025 |
Show all 78 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seagen INC. | $489.37 | 2019-2023 | Adcetris, Tukysa |
| Eisai INC. | $479.35 | 2019-2025 | |
| Janssen Biotech, INC. | $478.96 | 2019-2025 | Rybrevant, Erleada, Darzalex |
| Celgene Corporation | $467.90 | 2019-2025 | Reblozyl, Opdivo |
| Daiichi Sankyo INC. | $455.94 | 2019-2025 | Enhertu, Datroway |
| Alexion Pharmaceuticals, INC. | $440.41 | 2019-2025 | Koselugo, Ultomiris, Soliris |
| Taiho Oncology, INC. | $395.78 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $393.84 | 2019-2025 | |
| Tersera Therapeutics LLC | $374.48 | 2021-2025 | Xermelo, Zoladex |
| Gilead Sciences, INC. | $325.94 | 2021-2025 | Trodelvy |
| Abbvie INC. | $263.54 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $261.65 | 2019-2025 | Vonvendi, Iclusig |
| Array Biopharma INC | $247.29 | 2020-2025 | Mektovi, Braftovi, Lorbrena |
| Sumitomo Pharma America, INC. | $228.28 | 2023-2024 | Orgovyx |
| Sanofi-Aventis U.S. LLC | $223.52 | 2020-2021 | |
| Puma Biotechnology, INC. | $193.60 | 2022-2025 | |
| Dova Pharmaceuticals | $183.25 | 2019-2021 | |
| Agios Pharmaceuticals, INC. | $182.80 | 2023-2025 | Pyrukynd |
| Teva Pharmaceuticals USA, INC. | $181.05 | 2019-2020 | |
| Apellis Pharmaceuticals, INC. | $180.82 | 2022-2025 | Empaveli |
| Karyopharm Therapeutics INC. | $177.06 | 2020-2025 | Xpovio |
| Global Blood Therapeutics, INC. | $175.11 | 2020-2022 | |
| Beigene USA, INC. | $154.27 | 2020-2024 | Brukinsa |
| Deciphera Pharmaceuticals INC. | $141.40 | 2021-2025 | Qinlock, Romvimza, Tgct |
| Springworks Therapeutics, INC. | $130.63 | 2024-2025 | Ogsiveo, Gomekli |
| Lilly USA, LLC | $130.52 | 2019-2023 | Verzenio, Jaypirca |
| Verastem, INC. | $128.97 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $121.20 | 2022 | |
| Adc Therapeutics America, INC. | $104.57 | 2022-2025 | |
| Jazz Pharmaceuticals INC. | $99.80 | 2019-2022 | |
| Amag Pharmaceuticals, INC. | $98.71 | 2019-2022 | |
| Tesaro, INC. | $92.23 | 2019 | |
| Secura Bio, INC. | $87.49 | 2020-2024 | Copiktra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $75.59 | 2019-2021 | |
| Recordati_rare_diseases_inc. | $69.10 | 2024-2025 | Sylvant, Enjaymo |
| Pharmacyclics LLC, An Abbvie Company | $61.12 | 2019-2023 | Imbruvica |
| Emd Serono, INC. | $59.31 | 2019-2021 | |
| Stemline Therapeutics INC. | $59.26 | 2023-2024 | Orserdu |
| Exelixis INC. | $58.47 | 2022-2023 | Cabometyx |
| Foundation Medicine, INC. | $55.23 | 2021-2022 | |
| Ipsen Biopharmaceuticals, INC | $50.25 | 2019-2022 | |
| Pharmacosmos Therapeutics INC. | $48.73 | 2021-2025 | Monoferric |
| Myovant Sciences INC. | $48.50 | 2021-2022 | |
| Acrotech Biopharma INC. | $47.27 | 2024 | Beleodaq |
| Cti Biopharma Corp. | $46.45 | 2022-2023 | Vonjo |
| Amicus Therapeutics, INC. | $44.47 | 2024-2025 | Opfolda, Pombiliti |
| Servier Pharmaceuticals LLC | $42.34 | 2021-2022 | |
| Shire North American Group INC | $37.81 | 2019 | |
| Kyowa Kirin, INC. | $35.05 | 2019-2021 | |
| Kite Pharma, INC. | $33.64 | 2022 | |
| Clovis Oncology, INC. | $28.02 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $23.23 | 2019 | |
| Tg Therapeutics, INC. | $22.00 | 2021 | |
| Immunomedics, INC. | $20.68 | 2020 | |
| Shield Therapeutics INC | $20.56 | 2023 | Accrufer |
| Morphosys, US INC. | $19.93 | 2022 | |
| Medtronic, INC. | $18.97 | 2025 | Synchromedii |
| Eli Lilly and Company | $18.56 | 2019 | |
| Alnylam Pharmaceuticals INC. | $18.55 | 2022 | |
| Roche Diagnostics Corporation | $17.07 | 2020 | |
| Geron Corporation | $16.69 | 2025 | Rytelo |
| Mirati Therapeutics, INC. | $15.74 | 2023 | Krazati |
| Acceleron Pharma, INC. | $15.63 | 2020 |
Drugs and devices associated with these payments
Rezlidhia $920Tavalisse $920Keytruda $720Besremi $550Opdivo $523Fotivda $516Orgovyx $412Enhertu $397Ojjaara $392Fabhalta $371Lenvima $343Doptelet $340Venclexta $333Xtandi $304Scemblix $267Jakafi $257Reblozyl $217Opdualag $206Tecentriq $186Braftovi $185Mektovi $185Gavreto $181Talzenna $180Tukysa $167Pyrukynd $166Ibrance $166Kisqali $141Xermelo $140Trodelvy $139Lorbrena $135Promacta $133Lynparza $130Calquence $127Imfinzi $125Koselugo $122Welireg $115Xpovio $114Nubeqa $107Xofigo $107Ogsiveo $99.47Nexviazyme $98.90Rybrevant $96.77Tagrisso $93.59Qinlock $92.17Kyprolis $84.58Brukinsa $81.35Xalkori $80.97Nplate $80.69Xgeva $80.69Empaveli $79.08Vonvendi $77.25Zoladex $75.32Enjaymo $70.36Stivarga $70.24Vitrakvi $70.24Adcetris $68.45Tecentriq Hybreza $64.74Vonjo $60.92Orserdu $59.26Keytruda Qlex $55.56Ultomiris $55.15Oxbryta $52.55Polivy $50.08Lunsumio $50.08Tasigna $49.33Paxlovid $48.77Verzenio $48.06Beleodaq $47.27Erleada $45.05Darzalex $44.48Cablivi $44.22Lumakras $43.54Sylvant $42.96Sarclisa $41.41Talvey $40.01Inqovi $39.82Lonsurf $39.82Zynlonta $39.44Monoferric $35.70Soliris $35.49Copiktra $35.46Comirnaty $34.82Jaypirca $33.53Padcev $33.50Alecensa $33.08Gomekli $31.16Inlyta $30.91Wayrilz $30.83Romvimza $30.17Xospata $28.92Jivi $28.87Iclusig $27.07Datroway $24.75Tgct $23.49Piqray $23.15Nerlynx $21.74Bosulif $21.43Besponsa $21.43Accrufer $20.56Imbruvica $19.88
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ester Pollard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.